Bate Clive, Veerhuis Robert, Eikelenboom Piet, Williams Alun
Institute of Comparative Medicine, Department of Veterinary Pathology, Glasgow University Veterinary School, Bearsden Road, Glasgow G61 1QH, UK.
Neuroreport. 2004 Jun 28;15(9):1427-30. doi: 10.1097/01.wnr.0000132203.76836.16.
Activated microglia are closely associated with neuronal damage in Alzheimer's disease. In the present study, neurons exposed to low concentrations of amyloid-beta1-42, a toxic fragment of the amyloid-beta protein, were killed by microglia in a process that required cell-cell contact. Pre-treating microglia with polyclonal antibodies to the CD14 protein, or treating neurons exposed to amyloid-beta1-42 with a CD14-IgG chimera, prevented the killing of amyloid-beta1-42 damaged neurons by microglia. Moreover, microglia from CD14 null mice failed to kill amyloid-beta1-42 damaged neurons. Increased neuronal survival was accompanied by a significant reduction in the production of interleukin-6 indicative of reduced microglial activation. These results indicate an important role for CD14 in the recognition and subsequent killing of amyloid-beta damaged neurons by microglia.
活化的小胶质细胞与阿尔茨海默病中的神经元损伤密切相关。在本研究中,暴露于低浓度β-淀粉样蛋白1-42(β-淀粉样蛋白的有毒片段)的神经元,在一个需要细胞间接触的过程中被小胶质细胞杀死。用针对CD14蛋白的多克隆抗体预处理小胶质细胞,或用CD14-IgG嵌合体处理暴露于β-淀粉样蛋白1-42的神经元,可防止小胶质细胞杀死β-淀粉样蛋白1-42损伤的神经元。此外,来自CD14基因敲除小鼠的小胶质细胞无法杀死β-淀粉样蛋白1-42损伤的神经元。神经元存活率的提高伴随着白细胞介素-6产生的显著减少,这表明小胶质细胞的活化程度降低。这些结果表明CD14在小胶质细胞识别并随后杀死β-淀粉样蛋白损伤的神经元中起重要作用。